drugset / Trial / NCT02787057

Vancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dialysis (PD)-Related Peritonitis

NCT02787057

Completed 80 enrolled Peking University First Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Intra-peritoneal administration of antibiotics covering both gram-positive and gram-negative organisms was recommended as first-line regimen for the management of peritoneal dialysis related peritonitis. Oral administration of quinolones can also achieve effective serum concentrations, and is more convenient and economical. We conducted a pilot randomized controlled study to compare the effects on peritonitis cure and relapsing rates between oral moxifloxacin plus IP vancomycin and conventional IP vancomycin plus ceftazidime.

Timeline

Start
2012-11
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftazidime Small molecule 1 g Other
Comparator Moxifloxacin Small molecule 400 mg Oral
Background Vancomycin Other / unclassified 1 g Other